Tokyo, Japan

Go Ohtani

This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1989-1991.


% Patents Active = 100.0

Average Co-Inventor Count = 4.4

ph-index = 2

Forward Citations = 85(Granted Patents)


Company Filing History:


Years Active: 1989-1991

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Go Ohtani: Innovator in Pharmaceutical Composition

Introduction

Go Ohtani is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative patents. With a total of 2 patents, Ohtani's work focuses on enhancing the stability and efficacy of pharmaceutical compositions.

Latest Patents

Ohtani's latest patents include a lyophilized pharmaceutical composition of a neocarzinostatin derivative. This composition is created by dissolving the neocarzinostatin derivative along with a stabilizing agent in an aqueous buffer solution. The method involves adjusting the pH, sterilizing the solution, and lyophilizing it to ensure stability. Another significant patent is for an injectable composition of nicardipine hydrochloride. This composition maintains its desired concentration and can be stored stably for extended periods, showcasing Ohtani's commitment to improving pharmaceutical formulations.

Career Highlights

Go Ohtani is associated with Yamanouchi Pharmaceutical Company Ltd., where he has been instrumental in developing innovative pharmaceutical solutions. His work has contributed to advancements in drug formulation and delivery systems.

Collaborations

Ohtani has collaborated with notable coworkers, including Katayasu Ogawa and Mitsugu Kobayashi. These collaborations have further enriched his research and development efforts in the pharmaceutical industry.

Conclusion

Go Ohtani's contributions to pharmaceutical innovations reflect his dedication to improving drug stability and efficacy. His patents are a testament to his expertise and commitment to advancing healthcare solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…